Disappearance of the Defining Organized Ultrastructural Lesion in CLL-Associated Monoclonal Immunotactoid Glomerulopathy After Ibrutinib Therapy

Disappearance of the Defining Organized Ultrastructural Lesion in CLL-Associated Monoclonal Immunotactoid Glomerulopathy After Ibrutinib Therapy | ReachRx